Head and neck squamous cell carcinomas (HNSCCs) are aggressive diseases with a
dismal patient prognosis. Despite significant advances in treatment modalities, the five-year …

Oral mucositis secondary to head and neck chemoradiation displays a complex molecular
pathogenesis involving epithelial and microvascular injury, release of pro-inflammatory …

Oral mucositis is one of the most frequent complications after chemotherapy or radiotherapy
or a combination of both. There is no standard therapy for its prevention or treatment …

Background One of the most common complications of cancer chemotherapy is oral
mucositis (OM). OM affects more than 75% of patients undergoing chemotherapy and …

Worldwide, the incidence of cancer is on the rise. Current cancer treatments include
chemotherapy, radiation therapy, and surgery. Chemotherapy and radiation treatment are …

Background Oral mucositis (OM) is a common toxicity of stem cell transplantation (SCT). We
sought to evaluate OM burden, risk factors, and implications in a cohort of allogeneic‐SCT …

Radiation-induced oral mucositis (RIOM) is a common side effect after radiotherapy (RT) in
head and neck cancer (HNC) patients. RIOM patients with severe pain have difficulty in …

Abstract Purpose of Review Management of head and neck cancer (HNC) typically involves
a morbid combination of surgery, radiation, and systemic therapy. As the number of HNC …

Simple Summary Mesenchymal conversion occurring in malignant epithelial neoplasms is
undesirable in tumors since it promotes more aggressive tumor behavior. This phenomenon …

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common malignancy
worldwide, accounting for approximately 6% of all cancer cases and responsible for an …